![PHD bio science](https://parsers.vc/logo/348d7c47-e9f8-401f-a91f-c3cace6e35e8-0.png)
We are developing an enzyme inhibitor with pico-‐molar binding affinity and minimal toxicity as a once daily, oral therapeutic for the treatment of triple-‐negative breast cancer.
For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com
Employees: 11-50
Founded date: 2008
Investors 2
Date | Name | Website |
- | Checkmate ... | checkmatec... |
- | FirstXFoun... | firstxfoun... |